I agree. I want to buy into PIQ as I think their products with IP are potentially huge, but the lack of a distribution plan is holding me back.
I was in the pharma/diagnostic market for 35 years, including a long period in the USA. Every time I hear about the 'direct to consumer' marketing plan I step back from the 'BUY' button. Telix cracked the US diagnostic market rapidly with a great partnership with Cardinal. IMO, that is the way to penetrate the US market. A company the size of PIQ going it alone in the USA looks far too challenging.
I would like to hear from Sonic Healthcare as to why the distribution agreement failed, or more detail on what/why milestones were not met. With the potential of the test I struggle to comprehend how a company like Sonic would not meet milestones.
As mentioned by other posts here, marketing/distribution announcements may be coming. I will be watching ready to buy when they arrive.
PIQ Price at posting:
66.0¢ Sentiment: Buy Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)